ID16642A - Antagonis reseptor muskarinik oksa-dan tia diazol - Google Patents

Antagonis reseptor muskarinik oksa-dan tia diazol

Info

Publication number
ID16642A
ID16642A IDP970521A ID970521A ID16642A ID 16642 A ID16642 A ID 16642A ID P970521 A IDP970521 A ID P970521A ID 970521 A ID970521 A ID 970521A ID 16642 A ID16642 A ID 16642A
Authority
ID
Indonesia
Prior art keywords
oksa
diazol
tia
muscarinic receptors
muscarinic
Prior art date
Application number
IDP970521A
Other languages
English (en)
Indonesian (id)
Inventor
Alexander Roderick Mackenzie
Anthony Wood
Robert John Bass
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ID16642A publication Critical patent/ID16642A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDP970521A 1996-02-22 1997-02-21 Antagonis reseptor muskarinik oksa-dan tia diazol ID16642A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
ID16642A true ID16642A (id) 1997-10-23

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970521A ID16642A (id) 1996-02-22 1997-02-21 Antagonis reseptor muskarinik oksa-dan tia diazol

Country Status (42)

Country Link
US (1) US5977142A (fr)
EP (1) EP0885218B1 (fr)
JP (1) JP3148252B2 (fr)
KR (1) KR100315934B1 (fr)
CN (1) CN1089340C (fr)
AP (1) AP751A (fr)
AR (1) AR005916A1 (fr)
AT (1) ATE200899T1 (fr)
AU (1) AU712230B2 (fr)
BG (2) BG102699A (fr)
BR (1) BR9707733A (fr)
CA (1) CA2247164C (fr)
CO (1) CO4650040A1 (fr)
CZ (1) CZ292650B6 (fr)
DE (1) DE69704701T2 (fr)
DK (1) DK0885218T3 (fr)
DZ (1) DZ2181A1 (fr)
ES (1) ES2156357T3 (fr)
GB (1) GB9603755D0 (fr)
GR (1) GR3036032T3 (fr)
HN (1) HN1997000020A (fr)
HR (1) HRP970098B1 (fr)
HU (1) HUP9900501A3 (fr)
ID (1) ID16642A (fr)
IL (1) IL125413A (fr)
IS (1) IS4803A (fr)
MY (1) MY129729A (fr)
NO (1) NO313414B1 (fr)
NZ (1) NZ331039A (fr)
OA (1) OA10838A (fr)
PE (1) PE42798A1 (fr)
PL (1) PL186879B1 (fr)
PT (1) PT885218E (fr)
RU (1) RU2162848C2 (fr)
SK (1) SK283461B6 (fr)
TN (1) TNSN97039A1 (fr)
TR (1) TR199801644T2 (fr)
TW (1) TW492961B (fr)
UA (1) UA61068C2 (fr)
WO (1) WO1997030994A1 (fr)
YU (1) YU35698A (fr)
ZA (1) ZA971513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
CA2438991C (fr) * 2001-02-21 2010-08-17 Nps Pharmaceuticals, Inc. Composes heteropolycycliques et leur utilisations en tant qu'antagonistes des recepteurs metabotropiques du glutamate
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (fr) * 2006-08-08 2008-02-14 Argenta Discovery Limited Composés chimiques
JP2010501533A (ja) * 2006-08-21 2010-01-21 アージェンタ ディスカバリー リミテッド Ｍ３レセプター調節物質として有用な窒素含有複素環化合物
WO2008096093A1 (fr) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Dérivés d'oxazole et de thiazole et leurs utilisations
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
BRPI0807004A2 (pt) * 2007-02-07 2014-04-15 Argenta Discovery Ltd Sal
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
TW200843759A (en) * 2007-02-15 2008-11-16 Argenta Discovery Ltd Compounds and their use II
WO2009098453A1 (fr) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (fr) * 2008-08-12 2010-02-18 Argenta Discovery Limited Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0619814A1 (fr) * 1991-12-31 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Derives d'oxadiazole a effet inhibiteur de l'acetylcholinesterase et agoniste muscarinique
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Also Published As

Publication number Publication date
CN1211981A (zh) 1999-03-24
BG63971B1 (bg) 2003-08-29
CN1089340C (zh) 2002-08-21
GR3036032T3 (en) 2001-09-28
CO4650040A1 (es) 1998-09-03
HRP970098A2 (en) 1999-04-30
WO1997030994A1 (fr) 1997-08-28
DZ2181A1 (fr) 2002-12-01
IS4803A (is) 1998-07-21
SK283461B6 (sk) 2003-08-05
KR19990087143A (ko) 1999-12-15
TR199801644T2 (xx) 1998-11-23
BG102699A (en) 1999-09-30
PE42798A1 (es) 1998-08-18
TW492961B (en) 2002-07-01
SK112398A3 (en) 2000-04-10
DE69704701T2 (de) 2001-08-16
HN1997000020A (es) 1997-06-05
AR005916A1 (es) 1999-07-21
NO313414B1 (no) 2002-09-30
US5977142A (en) 1999-11-02
AU712230B2 (en) 1999-11-04
JPH11504051A (ja) 1999-04-06
HRP970098B1 (en) 2001-12-31
AP751A (en) 1999-07-12
AP9700930A0 (en) 1997-04-30
NO983871D0 (no) 1998-08-21
RU2162848C2 (ru) 2001-02-10
UA61068C2 (en) 2003-11-17
CA2247164C (fr) 2004-11-16
KR100315934B1 (ko) 2002-03-21
CZ267898A3 (cs) 1999-08-11
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
CA2247164A1 (fr) 1997-08-28
IL125413A0 (en) 1999-03-12
EP0885218B1 (fr) 2001-05-02
ES2156357T3 (es) 2001-06-16
EP0885218A1 (fr) 1998-12-23
PT885218E (pt) 2001-08-30
TNSN97039A1 (fr) 2005-03-15
HK1018274A1 (en) 1999-12-17
ZA971513B (en) 1998-08-21
JP3148252B2 (ja) 2001-03-19
AU1601497A (en) 1997-09-10
BR9707733A (pt) 1999-07-27
DE69704701D1 (de) 2001-06-07
PL186879B1 (pl) 2004-03-31
IL125413A (en) 2002-09-12
HUP9900501A2 (hu) 1999-06-28
HUP9900501A3 (en) 2001-02-28
YU35698A (sh) 1999-07-28
NZ331039A (en) 1999-10-28
NO983871L (no) 1998-08-21
GB9603755D0 (en) 1996-04-24
DK0885218T3 (da) 2001-05-28
CZ292650B6 (cs) 2003-11-12
PL328633A1 (en) 1999-02-15
ATE200899T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
ID18003A (id) Antagonis muskarinik
ID24054A (id) Turunan turunan benzimidazol
DE69826850D1 (de) Kopfhöreranordnung
DE69738190D1 (de) Hörkapsel
EP0986385A4 (fr) Antagonistes de gonadoliberine
ID24612A (id) Hidrogenolisis gliserol
ID23168A (id) Reseptor anatagonis vitronektin
DE69830355D1 (de) Kraftstofftankdeckel
DE69819580D1 (de) Kraftstofftankdeckel
DE69822240D1 (de) Kraftstofftankdeckel
DE59809295D1 (de) Schweissbrenner
DE69830356D1 (de) Kraftstofftankdeckel
NO995492L (no) Algicider
DE59809195D1 (de) Gebläsebrenner
DE69705281D1 (de) Aschenbecher
DE19848663B4 (de) Schutzhelm
KR970043932U (ko) 숯 착화장치
KR980000205U (ko) 재떨이
KR980003659U (ko) 점화장치
SE9703444D0 (sv) Headset
KR970048716U (ko) 전복양식판
IT242808Y1 (it) Posacenere
FI3228U1 (fi) Savustusuuni
NO964050D0 (no) Fakkel
BR7702028U (pt) Rodos